tiprankstipranks
NewAmsterdam Pharma Company (NAMS)
NASDAQ:NAMS
US Market

NewAmsterdam Pharma Company (NAMS) Ownership - Who Owns NewAmsterdam Pharma Company?

57 Followers

NewAmsterdam Pharma Company (NAMS) Ownership Overview

7.66%0.05%3.24%89.05%
3.24% Other Institutional Investors
89.05% Public Companies and
Individual Investors
The ownership structure of NewAmsterdam Pharma Company (NAMS) stock is a mix of institutional, retail and individual investors. Approximately 3.29% of the company’s stock is owned by Institutional Investors, 7.66% is owned by Insiders and 89.05% is owned by Public Companies and Individual Investors.
The ownership structure of NewAmsterdam Pharma Company (NAMS) stock is a mix of institutional, retail and individual investors. Approximately 3.29% of the company’s stock is owned by Institutional Investors, 7.66% is owned by Insiders and 89.05% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Mar 28, 2024
James Topper
Director
Bought$181224
Feb 21, 2024
Louis Lange
Director
Bought$95000

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2023Sold$87840880

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
8,024,565Institution8.99%158,404,913
7,864,000Institution8.81%155,235,360
2,535,723Institution2.84%50,055,172
1,383,800Institution1.55%27,316,212
47,324Institution0.05%934,176
213Institution<0.01%4,205

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
47,324Institution0.05%934,176

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
213Institution<0.01%4,205

FAQ

Who Owns NewAmsterdam Pharma Company (NAMS)?
According to the latest TipRanks data, approximately 3.24% of the company's stock is held by institutional investors, 7.66% is held by insiders, and 89.05% is held by retail investors.
    What percentage of NewAmsterdam Pharma Company (NAMS) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 3.24% of NewAmsterdam Pharma Company (NAMS) stock is held by institutional investors.
      What percentage of NewAmsterdam Pharma Company (NAMS) stock is held by retail investors?
      According to the latest TipRanks data, approximately 89.05% of NewAmsterdam Pharma Company (NAMS) stock is held by retail investors.
        Who owns the most shares of NewAmsterdam Pharma Company (NAMS)?
        Andreas Halvorsen owns the most shares of NewAmsterdam Pharma Company (NAMS).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis